Amiotrófiás laterálszklerózis (ALS): vizsgálatok itt: Szlovénia
3 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleDysphagia, QoL and Attitudes Towards PEG in ALS Patients
- Where
- Ljubljana
- Életkor
- 18 év and over
- People
- 60
- Run by
- University Rehabilitation Institute, Republic of Slovenia
See details and how to joinNCT05336760 - 3. fázisNot yet taking people in SzlovéniaEfficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients
- Életkor
- 18 év to 80 év
- People
- 412 worldwide
- Run by
- AB Science
See details and how to joinNCT07174492 · EU 2024-511244-12-01 - 3. fázisTaking peopleEfficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Where
- Ljubljana
- Életkor
- 18 év to 81 év
- People
- 495 worldwide
- Run by
- AB Science
See details and how to joinNCT03127267